Bank of Montreal’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-22,524
Closed -$70K 4152
2022
Q1
$70K Buy
+22,524
New +$80.7K ﹤0.01% 3727
2021
Q4
Sell
-117,966
Closed -$1.01M 3559
2021
Q3
$1.01M Buy
+117,966
New +$958K ﹤0.01% 2487
2021
Q2
Sell
-1,698
Closed -$15K 3947
2021
Q1
$15K Sell
1,698
-5,200
-75% -$49.6K ﹤0.01% 4174
2020
Q4
$62K Buy
6,898
+4,470
+184% +$37.4K ﹤0.01% 3838
2020
Q3
$19K Sell
2,428
-850
-26% -$7.67K ﹤0.01% 3856
2020
Q2
$33K Buy
3,278
+2,756
+528% +$25.3K ﹤0.01% 3620
2020
Q1
$4K Sell
522
-3,954
-88% -$20K ﹤0.01% 3711
2019
Q4
$17K Buy
4,476
+1,791
+67% +$7.81K ﹤0.01% 4383
2019
Q3
$14K Buy
2,685
+164
+7% +$954 ﹤0.01% 4263
2019
Q2
$17K Buy
+2,521
New +$17.3K ﹤0.01% 4261
2019
Q1
Sell
-434
Closed -$4K 4392
2018
Q4
$4K Sell
434
-238
-35% -$2.36K ﹤0.01% 4146
2018
Q3
$9K Buy
672
+470
+233% +$5.89K ﹤0.01% 3945
2018
Q2
$2K Buy
+202
New +$1.91K ﹤0.01% 4335
2016
Q1
Sell
-27,400
Closed -$153K 4217
2015
Q4
$153K Buy
+27,400
New +$187K ﹤0.01% 2567

Other funds holding CTSO

Bank of Montreal's CTSO Position: Q2 2022 in Review

Bank of Montreal sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 22,524 shares — an estimated $70K sold.

Bank of Montreal first reported a position in CTSO in Q4 2015 and held it in 14 quarters. The position peaked at $1.01M in Q3 2021. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Bank of Montreal reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 22,524 Cytosorbents Corp shares in Q2 2022, an estimated $70K.
  • Bank of Montreal first reported a position in Cytosorbents Corp in Q4 2015 and held it in 14 quarters.
  • Bank of Montreal's Cytosorbents Corp position peaked at $1.01M in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.